$NUTX

At 9:30 a.m. Central time on Nov. 6, Nutex Health will discuss its results.

Nutex Health (NASDAQ: NUTX) will host its Q3 2026 earnings call on Nov. 6, 2026, at 9:30 a.m. CT. The company will discuss financial performance and provide a business update. A transcript and recording will be available post-event on its website. Nutex operates 28 healthcare facilities across 12 states.

Original reporting
Published Oct 19, 2026, 9:30 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 19, 2026, 9:32 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$NUTX
Neutral
high confidence
Mentioned
$NUTX
Relevance
4/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$NUTXNeutralLow
01

Why it matters

The announcement itself is informational; no material impact until earnings are released.

02

Market read

The article serves as a routine earnings‑call notice with limited trading relevance.

03

What to watch

Analysts may be watching for updates on Nutex's real‑estate or population‑health divisions, but no specifics are provided.

Relevance 4/10Novelty 2/10Timing: pre‑market today

Background

Nutex Health is a NASDAQ‑listed healthcare management company that operates hospitals, population‑health networks, and real‑estate assets.

Company-level read

Ticker impact

$NUTXNeutralHigh confidence
Context

Nutex Health announced its Q3 earnings conference call scheduled for Nov 6, 2026 at 9:30 a.m. CT.

Expected impact

neutral with no immediate directional pressure

Evidence & confidence

No earnings numbers or guidance were disclosed; traders typically wait for the actual results before acting.

Market effects

None disclosed; the announcement does not affect the broader healthcare management sector.

Limited to U.S. investors tracking Nutex Health.

Low

Counterpoint

Some traders may view the call as an opportunity to short ahead of a potentially weak earnings release.

Key entities

  • Nutex Health Inc.

    NASDAQ: NUTX, healthcare management and operations firm.

Related articles

$NUTXMed

Fifth Circuit Rejects "Ghost Rates" in Federal QPA Calculations Under the No Surprises Act

Nutex Health (NASDAQ: NUTX) commented on a Fifth Circuit ruling invalidating federal QPA calculation rules under the No Surprises Act, which the company says artificially deflated payments. The court ruled insurers cannot include non-negotiated 'ghost rates' and must include bonus payments in QPA calculations. Nutex Health expects this to lead to fairer upfront payments for providers. The ruling may impact the company's financials, but the timeline for new regulations is uncertain.

$NUTXMedAI 8/10

Nutex Health (NUTX) Q2 2026 Earnings Call Transcript

Nutex Health (NUTX) reported Q2 2026 results on an earnings call. Total revenue fell to $210.8M from $244.0M. Net income rose to $65.8M, diluted EPS to $9.38, and adjusted EBITDA to $90.0M. Management cited lower contract services costs from a HaloMD amendment and higher patient visits, plus a hospital expansion pipeline.

$NUTXMedAI 8/10

Nutex Health Q2 Profit Soars As IDR Cost Reductions Drive Margin Gains

Nutex Health (NUTX) reported Q2 2026 results, with net income of $65.8M and diluted EPS of $9.38, versus a net loss of $17.7M a year earlier. Revenue fell 13.6% to $210.8M. The company cited IDR-related cost reductions, including a $52.3M contract services expense decline, and expects normalized historical expenses to drop 25% to 30% prospectively. Shares rose 14.88% to $186.19.

$NUTXMed

NUTEX HEALTH REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS

Nutex Health Inc. (NASDAQ: NUTX) reported Q2 2026 results for the three and six months ended June 30, 2026. Net income attributable rose to $65.8M (diluted EPS $9.38) for Q2, versus a loss in 2025. Six-month net income was $112.6M (EPS $15.87). Revenue fell to $427.2M for six months. Operating cash flow was $109.7M. Hospital visits increased.

$NUTXMed

NUTEX HEALTH REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS

Nutex Health Inc. (NUTX) filed an SEC Form 8-K — Results of Operations and Financial Condition. NUTEX HEALTH REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS HOUSTON, TX − (PRNewswire) – AUGUST 6, 2026 – Nutex Health Inc. (“Nutex Health” or the “Company”) (NASDAQ: NUTX), today announced financial results for the three and six months ended June 30, 2026. Nutex Health is a physi